What is 4DMedical?
4DMedical Limited (ASX:4DX) operates at the intersection of software engineering and clinical pulmonology. The company specializes in the deployment of sophisticated imaging technology that provides deep, quantitative insights into lung function and cardiopulmonary health. By integrating seamlessly into existing hospital workflows, 4DMedical empowers radiologists and pulmonologists to move beyond qualitative assessments, offering precise, patient-specific data that enhances surgical planning and disease monitoring. This technological edge is critical for addressing the rising global burden of respiratory conditions, positioning the company as a vital infrastructure provider in modern healthcare systems.
How much funding has 4DMedical raised?
4DMedical has raised a total of $135M across 3 funding rounds:
Share Placement
$20M
Stock/Share Issuance
$15M
Stock/Share Issuance
$100M
Share Placement (2023): $20M, investors not publicly disclosed
Stock/Share Issuance (2025): $15M, investors not publicly disclosed
Stock/Share Issuance (2026): $100M, investors not publicly disclosed
Key Investors in 4DMedical
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for 4DMedical?
With the infusion of $100M, 4DMedical is well-positioned to accelerate its international market penetration and further refine its AI-driven diagnostic suite. The strategic roadmap likely involves scaling operational capacity to meet the increasing demand for high-precision imaging in clinical settings. As the company matures, the focus will shift toward expanding its clinical application library and strengthening its competitive moat through continued investment in R&D. Investors will be monitoring the firm's ability to translate this capital into sustained revenue growth and broader adoption across major healthcare networks, ensuring that its proprietary software becomes the standard of care for complex respiratory diagnostics.
See full 4DMedical company page
